< Go to adacap.com| This site is for health care professionals only

Explore Compounds

[177Lu]Lu-DOTA-TATE

 

SSTR-targeted peptide receptor radionuclide therapy

[177Lu]Lu-PSMA-617

 

Investigational PSMA-targeted radioligand therapy

[68Ga]Ga-FF58

 

Integrin αvβ3 and αvβ5 small molecule ligand (radiolabeled with Gallium-68)

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.
MOA data are based on in vitro/in vivo data. Clinical benefit is unknown.

Explore Pipeline on adacap.com Explore Clinical Trials